Chen Schor
CIK 1340875 · President & CEO · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$188.1K
Companies
6
Total Filings
66
Lifetime Open-Market Net
-$5.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACET | President & CEO | 9,536 | $8.20 | $78.2K | -$5.13M | 35 | 2026-06-23 |
| KPTI | Director | 15,508 | $7.09 | $110.0K | $0 | 7 | 2026-05-26 |
| Adicet Bio, Inc. (TORC) Delisted | President and CEO | 319,480 | — | — | $53.5K | 6 | 2019-12-06 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted | Director | 8,371 | $0.75 | $6.3K | $0 | 4 | 2018-12-21 |
| MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted | Former President and CEO | 37,178 | — | — | $0 | 5 | 2016-07-22 |
| EPIX Pharmaceuticals, Inc. (EPIX) Delisted | Chief Business Officer | 7,312 | $0.20 | $1.5K | $0 | 6 | 2009-03-03 |
Recent Filings · Page 2 of 7
66 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-02 | ACET | Mixed | −23,208 | -$31.9K | EDGAR |
| 2023-09-29 | ACET | Notice (144) | −5,500 | -$7.5K | EDGAR |
| 2023-08-16 | ACET | Mixed | — | $0 | EDGAR |
| 2023-05-25 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2023-01-26 | ACET | Grant (A) | +85,500 | $0 | EDGAR |
| 2022-11-15 | ACET | Sell (S) | −39,955 | -$811.2K | EDGAR |
| 2022-11-09 | ACET | Sell (S) | −30,000 | -$571.5K | EDGAR |
| 2022-11-04 | ACET | Sell (S) | −25,313 | -$456.7K | EDGAR |
| 2022-10-04 | ACET | Tax (F) | −21,288 | -$302.7K | EDGAR |
| 2022-09-16 | ACET | Sell (S) | −952 | -$17.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.